The global medical bone densitometer market is projected to witness a considerable growth rate by exhibiting a CAGR of 6.3%, during the forecast period.The global medical bone densitometer size is projected to show a lucrative growth during the forecast period. The osteoporosis in menopausal women is a key contributing factor of the market. According to the International Osteoporosis Foundation, approximately 200 million women are affected by osteoporosis across the globe and about one in every three women over the age of 50 years, were found to suffer from osteoporotic fractures. Osteoporosis is a condition that causes bone to become thin and porous and increased risk of breaking a bone. Bone density test offersdiagnoses and treatment of osteoporosis before occurs ofa broken bone. The increasing aging population and improved treatment for preventing fractures is expected to flourishing the bone density market.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/global-medical-bone-densitometers-market
According to National Institutes of Health osteoporosis, lifestyle habits include smoking and sedentary lifestyle. A bone mineral density (BMD) test is can provide a snapshot of your bone health. The test can measures osteoporosis that regulate the risk for fractures (broken bones), and identify the response to osteoporosis treatment and diagnosis. The most commonly used BMD test is called a central dual-energy x-ray absorptiometry, or central DXA test and it is painless like having an x-ray. The test can measure bone density at your hip and lumbar spine.There are many risk factors for osteoporosis includes smoking, family history of hip fractures, excessive alcohol consumption and post- menopausal women not taking estrogen. Thus, such test of osteoporosis is flourishing the growth of the medical bone densitometer market.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/global-medical-bone-densitometers-market
As per the World Health Organization (WHO), osteoporosis is identify based on the following bone density levels that includeA T-score within 1 SD of the young adult mean indicates normal bone density. A T-score of 1 to 2.5 SD below the young adult mean indicates low bone mass. A T-score of 2.5 SD or more below the young adult mean indicates the presence of osteoporosis. Bone density testing is utilized in diagnosis and treatment of osteoporosis that predicts chances of fracturing of bone in the future and measures the rate of bone loss. The dieases may occur in alcoholics, hyperthyroidiem, gastrointestinal diseases and people with anorexia. Osteoporosis has result in antiseizure medications, proton pump inhibitors, steroids, selective serotive serotonin reuptake inhibitors and chemoptherapy. Thereby, such factors driving the growth of the medical bone densitometer market during the forecast period.
Global Medical Bone Densitometer Market – Segmentation
By Technology
- DEXA
- Ultrasound
By Application
- Central Scan
- Peripheral Scan
Global Medical Bone Densitometer Market – Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
Company Profiles
- BeamMed Ltd.
- CompuMed Inc.
- DMS Group
- FURUNO ELECTRIC CO., LTD.
- General Electric Co.
- Hitachi Ltd.
- Hologic, Inc.
- Medonica Co. Ltd.
- Nanoomtech Co., Ltd.
- Oscare Medical Oy
- Osteometer Meditech Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
